Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD-CARhE: Azithromycin Guided by Mucus Rheology vs Standard Management in COPD
2019-004182-41Phase 2Active
- Sponsor
- CHU Montpellier
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of azithromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Number of exacerbations over 12 months. Started Dec 2019; status: active.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2019-004182-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004182-41.